Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Liabilities and Shareholders Equity (2019 - 2025)

Volitionrx's Liabilities and Shareholders Equity history spans 9 years, with the latest figure at $6.9 million for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity fell 26.58% year-over-year to $6.9 million; the TTM value through Dec 2025 reached $30.6 million, down 43.98%, while the annual FY2025 figure was $6.9 million, 26.58% down from the prior year.
  • Liabilities and Shareholders Equity reached $6.9 million in Q4 2025 per VNRX's latest filing, up from $6.4 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $35.2 million in Q2 2021 to a low of $6.4 million in Q3 2025.
  • Average Liabilities and Shareholders Equity over 5 years is $19.3 million, with a median of $18.3 million recorded in 2022.
  • Peak YoY movement for Liabilities and Shareholders Equity: soared 52.78% in 2023, then plummeted 66.37% in 2024.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $27.5 million in 2021, then plummeted by 33.45% to $18.3 million in 2022, then skyrocketed by 52.78% to $28.0 million in 2023, then plummeted by 66.37% to $9.4 million in 2024, then fell by 26.58% to $6.9 million in 2025.
  • Per Business Quant, the three most recent readings for VNRX's Liabilities and Shareholders Equity are $6.9 million (Q4 2025), $6.4 million (Q3 2025), and $8.7 million (Q2 2025).